(1)What are the reasons that the Draft Patents Amendment Bill, which is vital to pandemic readiness, access to medicines and to local manufacturing, has repeatedly been delayed;
(2) whether his department is experiencing external pressures from third parties such as trade entities from the United States trade and European Union to delay the Bill; if not, what is the position in this regard; if so, what are the details of the pressures;
(3) on what date is it envisaged that the Bill will be tabled in Parliament?